ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

Group Chairs: Research In “Crisis” ASCO Says NCTN Budgets Cut By 40 Percent, Warns of “Dangerous Disruption of Cancer Care”

April 4, 2014

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007